By AHRA Staff
November 2013—The AHRA would like to thank Mallinckrodt for its two year commitment to AHRA and the AHRA Education Foundation through the Expanding Excellence Campaign. As we come to the end of the first year of the relationship, we are grateful for Mallinckrodt’s support in offering educational opportunities to our membership.
Earlier this year, when Mallinckrodt confirmed its participation in the campaign, Rebecca Saunders, Sr. Marketing Director for Mallinckrodt said, “Mallinckrodt is very excited to partner with AHRA on the innovative Expanding Excellence Campaign. This collaborative partnership will enable us to continue to focus on and drive education around improved patient care.”
Ed Yoder, CRA, FAHRA, 2013-2014 President of the AHRA Board of Directors echoed, “AHRA and Mallinckrodt share a similar focus – to provide education towards the end result of better patient care. We’re grateful for their two year partnership and look forward to better serving our membership in practical ways through this relationship.”
Please join AHRA in thanking Mallinckrodt for its investment in the profession and partnership with AHRA and the AHRA Education Foundation. We look forward to another year of investing in the profession together.
About Mallinckrodt: Mallinckrodt is a global specialty pharmaceuticals business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s Specialty Pharmaceuticals segment includes branded and generic drugs, and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt has approximately 5,500 employees worldwide with sales in roughly 70 countries. To learn more about Mallinckrodt, please visit www.mallinckrodt.com.